These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34539374)

  • 1. Editorial: Neuroprotection in Synaptic Signalling During Neurological Disorders.
    Otero-Losada M; Wandosell FG; Capani F
    Front Synaptic Neurosci; 2021; 13():746487. PubMed ID: 34539374
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroprotection Through Rapamycin-Induced Activation of Autophagy and PI3K/Akt1/mTOR/CREB Signaling Against Amyloid-β-Induced Oxidative Stress, Synaptic/Neurotransmission Dysfunction, and Neurodegeneration in Adult Rats.
    Singh AK; Kashyap MP; Tripathi VK; Singh S; Garg G; Rizvi SI
    Mol Neurobiol; 2017 Oct; 54(8):5815-5828. PubMed ID: 27660271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington's disease.
    Tyebji S; Hannan AJ
    Prog Neurobiol; 2017 Jun; 153():18-45. PubMed ID: 28377290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering Discrete Synaptic Proteomes to Understand Neurological Disorders.
    Wang YZ; Savas JN
    Proteomes; 2018 Jul; 6(3):. PubMed ID: 30029459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Synaptic Diseases: From Biology to Potential Therapy.
    Wang H; Balice-Gordon R
    Front Synaptic Neurosci; 2022; 14():846099. PubMed ID: 35480634
    [No Abstract]   [Full Text] [Related]  

  • 6. Rab-mediated endocytosis: linking neurodegeneration, neuroprotection, and synaptic plasticity?
    Baskys A; Bayazitov I; Zhu E; Fang L; Wang R
    Ann N Y Acad Sci; 2007 Dec; 1122():313-29. PubMed ID: 18077583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.
    Lepeta K; Lourenco MV; Schweitzer BC; Martino Adami PV; Banerjee P; Catuara-Solarz S; de La Fuente Revenga M; Guillem AM; Haidar M; Ijomone OM; Nadorp B; Qi L; Perera ND; Refsgaard LK; Reid KM; Sabbar M; Sahoo A; Schaefer N; Sheean RK; Suska A; Verma R; Vicidomini C; Wright D; Zhang XD; Seidenbecher C
    J Neurochem; 2016 Sep; 138(6):785-805. PubMed ID: 27333343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational medicine of the glutamate AMPA receptor.
    Miyazaki T; Abe H; Uchida H; Takahashi T
    Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(1):1-21. PubMed ID: 33431723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synapse-to-Nucleus Signaling in Neurodegenerative and Neuropsychiatric Disorders.
    Parra-Damas A; Saura CA
    Biol Psychiatry; 2019 Jul; 86(2):87-96. PubMed ID: 30846302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges for the pharmacological treatment of neurological and psychiatric disorders: Implications of the Ca(2+)/cAMP intracellular signalling interaction.
    Bergantin LB; Caricati-Neto A
    Eur J Pharmacol; 2016 Oct; 788():255-260. PubMed ID: 27349146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions.
    Canas PM; Porciúncula LO; Simões AP; Augusto E; Silva HB; Machado NJ; Gonçalves N; Alfaro TM; Gonçalves FQ; Araújo IM; Real JI; Coelho JE; Andrade GM; Almeida RD; Chen JF; Köfalvi A; Agostinho P; Cunha RA
    eNeuro; 2018; 5(6):. PubMed ID: 30627646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of mitochondria dysfunction in the onset of neurodegenerative diseases.
    Cavallucci V; Nobili A; D'Amelio M
    J Biol Regul Homeost Agents; 2013; 27(2 Suppl):1-9. PubMed ID: 24813311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Na
    Pannaccione A; Piccialli I; Secondo A; Ciccone R; Molinaro P; Boscia F; Annunziato L
    Cell Calcium; 2020 May; 87():102190. PubMed ID: 32199208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone attenuates Aβ
    Wu Z; Wu H; Sun S; Wu H; Shi W; Song J; Liu J; Zhang Y; Bian F; Jia P; Hou Y
    Life Sci; 2020 Jul; 253():117360. PubMed ID: 32001269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic conditioning and the central nervous system: A new therapeutic opportunity for brain and spinal cord injuries?
    Baillieul S; Chacaroun S; Doutreleau S; Detante O; Pépin JL; Verges S
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1198-1206. PubMed ID: 28585890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Astrocyte-Targeted Therapeutic Strategies for Neurological Disorders.
    Miyazaki I
    Curr Pharm Des; 2017; 23(33):4933-4935. PubMed ID: 29022514
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycine, the smallest amino acid, confers neuroprotection against D-galactose-induced neurodegeneration and memory impairment by regulating c-Jun N-terminal kinase in the mouse brain.
    Ullah R; Jo MH; Riaz M; Alam SI; Saeed K; Ali W; Rehman IU; Ikram M; Kim MO
    J Neuroinflammation; 2020 Oct; 17(1):303. PubMed ID: 33059700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
    Soni N; Reddy BV; Kumar P
    Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional up-regulation of the M-current by retigabine contrasts hyperexcitability and excitotoxicity on rat hypoglossal motoneurons.
    Ghezzi F; Monni L; Nistri A
    J Physiol; 2018 Jul; 596(13):2611-2629. PubMed ID: 29736957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-Based Profiling of Synaptic Connectivity in Primary Neuronal Cell Culture.
    Verstraelen P; Van Dyck M; Verschuuren M; Kashikar ND; Nuydens R; Timmermans JP; De Vos WH
    Front Neurosci; 2018; 12():389. PubMed ID: 29997468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.